HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age.

Abstract
Recurrent thrombosis is a relatively frequent complication of venous thromboembolism (VTE) and represents an important cause of clinical and economic issues for health care systems worldwide. Rates of thrombosis increase with increasing age, with aging recognized to be a risk factor for thrombosis. Although D-dimer is now regarded as the biochemical gold standard for assisting the diagnosis of VTE and predicting the recurrent risk of thrombosis, the interpretation of D-dimer values with increasing age remains challenging due to many factors. These include the development of age-related changes in both the microcirculation and blood coagulation, which ultimately contribute to generate a hypercoagulable state and a gradual increase of D-dimer concentration with aging. Convincing evidence has now been provided that while D-dimer values may be effectively utilized for predicting the risk of recurrent thrombosis with increasing age, conventional cutoff values are inappropriate for older populations. In summary, analysis of the current scientific literature suggests that the adoption of age-dependent thresholds may increase the diagnostic effectiveness of this biomarker with increasing age.
AuthorsGiuseppe Lippi, Emmanuel J Favaloro, Gianfranco Cervellin
JournalSeminars in thrombosis and hemostasis (Semin Thromb Hemost) Vol. 40 Issue 6 Pg. 634-9 (Sep 2014) ISSN: 1098-9064 [Electronic] United States
PMID25099192 (Publication Type: Journal Article, Review)
CopyrightThieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Chemical References
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aging (blood)
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Humans
  • Middle Aged
  • Risk Factors
  • Thrombosis (blood)
  • Venous Thromboembolism (blood, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: